论文信息 - A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma - 字舞流文

A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma

I. Lossos | M. Coleman | P. Strati | C. Patti | M. Levy | L. Budde | P. R. Geethakumari | K. Higgins | R. Calvo | Rebecca Champion | Selay Lam | Shuo Ma | R. Champion